Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 5
2017 4
2018 3
2019 3
2021 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
van Gils T, Rootsaert B, Bouma G, Mulder CJ. van Gils T, et al. J Gastrointestin Liver Dis. 2017 Mar;26(1):93. doi: 10.15403/jgld.2014.1121.261.gil. J Gastrointestin Liver Dis. 2017. PMID: 28338121 Free article. No abstract available.
Mechanisms and management of refractory coeliac disease.
van Gils T, Nijeboer P, van Wanrooij RL, Bouma G, Mulder CJ. van Gils T, et al. Nat Rev Gastroenterol Hepatol. 2015 Oct;12(10):572-9. doi: 10.1038/nrgastro.2015.155. Epub 2015 Sep 8. Nat Rev Gastroenterol Hepatol. 2015. PMID: 26347156 Review.
Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study.
Cellier C, Bouma G, van Gils T, Khater S, Malamut G, Crespo L, Collin P, Green PHR, Crowe SE, Tsuji W, Butz E, Cerf-Bensussan N, Macintyre E, Parnes JR, Leon F, Hermine O, Mulder CJ; RCD-II Study Group Investigators. Cellier C, et al. Among authors: van gils t. Lancet Gastroenterol Hepatol. 2019 Dec;4(12):960-970. doi: 10.1016/S2468-1253(19)30265-1. Epub 2019 Sep 4. Lancet Gastroenterol Hepatol. 2019. PMID: 31494097 Clinical Trial.
Splenic volume differentiates complicated and non-complicated celiac disease.
van Gils T, Nijeboer P, van Waesberghe JHT, Coupé VM, Janssen K, Zegers JA, Nurmohamed SA, Kraal G, Jiskoot SC, Bouma G, Mulder CJ. van Gils T, et al. United European Gastroenterol J. 2017 Apr;5(3):374-379. doi: 10.1177/2050640616663571. Epub 2016 Aug 17. United European Gastroenterol J. 2017. PMID: 28507749 Free PMC article.
Gamma-Delta T Lymphocytes in the Diagnostic Approach of Coeliac Disease.
Nijeboer P, van Gils T, Reijm M, Ooijevaar R, Lissenberg-Witte BI, Bontkes HJ, Mulder CJJ, Bouma G. Nijeboer P, et al. Among authors: van gils t. J Clin Gastroenterol. 2019 May/Jun;53(5):e208-e213. doi: 10.1097/MCG.0000000000001060. J Clin Gastroenterol. 2019. PMID: 29782465
NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study.
Cheminant M, Bruneau J, Malamut G, Sibon D, Guegan N, van Gils T, Cording S, Trinquand A, Verkarre V, Lhermitte L, Brousse N, Jannot AS, Khater S, Frenzel L, Delarue R, Suarez F, Marçais A, Mulder CJ, Macintyre E, Asnafi V, Pouyet L, Bonnafous C, Lhospice F, Molina TJ, Meresse B, Cellier C, Cerf-Bensussan N, Hermine O; CELAC network°. Cheminant M, et al. Among authors: van gils t. Gut. 2019 Aug;68(8):1396-1405. doi: 10.1136/gutjnl-2018-317371. Epub 2018 Nov 17. Gut. 2019. PMID: 30448772
16 results